Clough Harbour & Associates LLP Company Profile

13:40 EDT 18th March 2018 | BioPortfolio

Driving a highway should be like a visit to the symphony,” CHA-founder and highway engineer John Clarkson said famously. He saw how the blacktop’s path could set a cadence, how reaching a hilltop could be a crescendo. John had a passion for engineering like none other.
While the diversity of our services has grown tremendously over the decades, one thing has remained constant. John’s vision - that, if well-designed, even the everyday can be extraordinary – still defines our every project.


III Winners CircleP.O. Box 5269
New York
United States of America


Phone: (518) 453-4500
Fax: (518) 458-1735

News Articles [224 Associated News Articles listed on BioPortfolio]



Harbour BioMed Raises Additional Capital in Series A+

Harbour BioMed of Shanghai has completed a Series A+ round of unspecified size. The funding was led by CDH Investments, a China PE firm, and joined by existing investor Advantech Capital. In late 2016...

Innovent Licenses Use of Harbour Biomed's Biologic Drug Discovery Platform

Suzhou's Innovent Biologics will use a proprietary H2L2 transgenic mouse platform owned by Harbour Biomed of Shanghai to discover new mAbs. Innovent, which already has 13 biologic candidates in develo...

David Harbour Just Made Another Amazing Twitter Promise To A Fan

“Stranger Things” star David Harbour will go to great lengths to please fans.

BeiGene, ImmunoChina on antibody deals with Harbour

Cancer company BeiGene acquired Harbour BioMed's H2L2 transgenic mouse platform, to be used in multiple programs over a perio -More- 

Centrexion raises $67mm in Series D round to fund Phase III trial for pain candidate CNTX4975

Pain-focused Centrexion Therapeutics Corp. raised $67mm in a Series D financing led by New Enterprise Associates. New and returning investors, including Quan Capital, ArrowMark Partners, investment fu...

BeiGene to Generate New mAbs Using Harbour BioMed's Mouse Platform

Beijing's BeiGene licensed multi-year rights to use Harbour BioMed's H2L2 transgenic mouse platform, which generates fully human therapeutic monoclonal antibodies. Harbour BioMed, a Shanghai company, ...

Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with BeiGene for ...

Harbour AntibodiesTimothy Miller90 Bridge Street, Suite 100Newton, MA 02478, USAtimothy.miller@harbourbiomed.comorHarbour BioMedXian Wu866 Halei Road, Suite 311Zhangjiang Hi-Tech ...

Drugs and Medications [205 Associated Drugs and Medications listed on BioPortfolio]

Topcare gas relief [Topco Associates LLC]

Topco Associates LLC. Gas Relief Drug Facts

Topcare antacid calcium [Topco Associates LLC]

Topco Associates LLC. Antacid Calcium Drug Facts

Topcare antacid calcium [Topco Associates LLC]

Topco Associates LLC. Antacid Calcium Drug Facts

Topcare milk of magnesia [Topco Associates LLC]

Topco Associates LLC. Milk of Magnesia Drug Facts

Topcare antacid [Topco Associates LLC]

Topco Associates LLC. Antacid Drug Facts

PubMed Articles [124 Associated PubMed Articles listed on BioPortfolio]

Settling fluxes and ecotoxicological risk assessment of fine sedimentary metals in Tema Harbour (Ghana).

Sediment traps were deployed in the Tema Harbour to estimate the settling fluxes of silt-clay particles and associated metals (Fe, Mn, Pb, Cr, Cu, Zn, Ni, Hg, Sn and As) and characterise their potenti...

Mitochondrial DNA reveals secondary contact in Japanese harbour seals, the southernmost population in the western Pacific.

In this study, we used relatively large number of samples (n = 178) and control region of mtDNA (454bp) to clearify the divergence history of Japanese harbour seals (Phoca vitulina stejnegeri) and phy...

Coming of age: - Do female harbour porpoises (Phocoena phocoena) from the North Sea and Baltic Sea have sufficient time to reproduce in a human influenced environment?

The harbour porpoise is the only cetacean species native to German waters. Since human pressures are suggested to shorten their reproductive lifespan, basic knowledge on reproduction is strongly requi...

Loop-mediated isothermal amplification (LAMP) assay-A rapid detection tool for identifying red fox (Vulpes vulpes) DNA in the carcasses of harbour porpoises (Phocoena phocoena).

Carcasses of wild animals are often visited by different scavengers. However, determining which scavenger caused certain types of bite marks is particularly difficult and knowledge thereof is lacking....

Plastic ingestion by harbour porpoises Phocoena phocoena in the Netherlands: Establishing a standardised method.

Stomach contents of harbour porpoises (Phocoena phocoena) collected in the Netherlands between 2003 and 2013 were inspected for the presence of plastic and other man-made litter. In 654 stomach sample...

Clinical Trials [58 Associated Clinical Trials listed on BioPortfolio]

Frailty and Mortality in Older Old With Severe Aortic Stenosis

BACKGROUND.- The frailty syndrome (FS) associates an increase in morbidity and mortality in the elderly patient. When severe and symptomatic, aortic stenosis (AS) is a disease with poor pr...

GORE VIABAHN® Versus Plain Old Balloon Angioplasty (POBA) for Superficial Femoral Artery (SFA) In-Stent Restenosis

This is a prospective, randomized, multi-center study recruiting patients with an in-stent restenosis in the superficial femoral artery. The safety and efficacity of the Viabahn endoprosth...

Endoscopic Resection of Gastric Subepithelial Masses, EndoResect Study

Gastric subepithelial masses might harbour gastrointestinal stromal tumors, which should get resected because of their malignant potential. To minimize the associated surgical trauma endos...

Tap to "Tap", Pathobiome Associates Health Care

The bacteria live in community and in some cases it is the combination of several microorganisms that facilitates transmission and pathogenicity. The concept of pathobiome follows from thi...

Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial

The study will assess the effectiveness of at-home vs. in-office induction for patients entering buprenorphine maintenance at Associates in Internal Medicine (AIM) primary care clinic.

Companies [744 Associated Companies listed on BioPortfolio]

Clough Harbour & Associates LLP

Driving a highway should be like a visit to the symphony,” CHA-founder and highway engineer John Clarkson said famously. He saw how the blacktop’s path could set a cadence, how reaching a hilltop ...

Harbour BioMed

Harbour BioMed is a global biopharmaceutical company discovering and developing innovative therapeutics for cancer, with a focus on immuno-oncology, and immunological diseases. Th...

Harbour Point Capital

Harbour Point Capital (“HPC”) is an independent private equity firm specializing in healthcare investing. The co-founders of HPC have worked together for eight years ...

Harbour Antibodies BV

Harbour Antibodies BV was established in 2006 to use transgenic mouse technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC (Rotterdam, the Netherlands)...

TA Associates TA Associates

Founded in 1968, TA Associates is one of the largest and most experienced middle market private equity firms. The firm has invested in over 400 companies and manages more than US ...

More Information about "Clough Harbour & Associates LLP" on BioPortfolio

We have published hundreds of Clough Harbour & Associates LLP news stories on BioPortfolio along with dozens of Clough Harbour & Associates LLP Clinical Trials and PubMed Articles about Clough Harbour & Associates LLP for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Clough Harbour & Associates LLP Companies in our database. You can also find out about relevant Clough Harbour & Associates LLP Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record